Zim Laboratories Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 63,847 shares,. Its Average Traded Price (ATP) is ₹141.67, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 35 @ ₹140.89.
Zim Laboratories has an upper circuit limit of ₹169.06 and a lower circuit limit of ₹112.72. The total value traded stands at ₹90.45 L, and the delivery percentage for the day is 37.28%.
The stock is currently traded with a market lot size of 1. Zim Laboratories also offers a dividend yield of 0%.
Zim Laboratories Share Price Chart
Zim Laboratories Share Key Metrics
Volume
63847.00
Market Cap
755.99 CR
LTQ@LTP
35@140.89
ATP
141.67
Var Margin
25 %
Circuit Range
112.72-169.06
Delivery %
37.28 %
Value
90.45 L
ASM/GSM
No
Market Lot
1
Zim Laboratories Resistance and Support
Pivot 139.74
Resistance
First Resistance
144.73
Second Resistance
148.44
Third Resistance
153.43
Support
First Support
136.03
Second Support
131.04
Third Support
127.33
Zim Laboratories Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Zim Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-04 | Quarterly Results |
| 2026-02-11 | Quarterly Results |
| 2026-01-21 | Others |
| 2025-11-12 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-20 | Audited Results |
| 2025-02-10 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-03 | Quarterly Results |
Zim Laboratories News
Zim Laboratories Ltd - 541400 - Please Find Enclosed Earnings Presentation For Q2 & H1 FY27
Zim Laboratories released its Q2 FY27 investor presentation. The company reported a 19% YoY increase in Q2 operating income to Rs.105.4 crores and highlighted securing TGA GMP certification for the Australian market.
Nov 04 2026 20:41:17
Zim Laboratories Ltd - 541400 - Board Meeting Outcome for Outcome Of The Board Meeting
Zim Laboratories reported Q2 FY27 cons. revenue of ₹105.45 crore, reflecting a 19% YoY growth. However, the company's net loss widened to ₹2.05 crore from ₹0.42 crore in Q2 FY26, driven by an increase in total expenses.
Nov 04 2026 14:43:10
Zim Laboratories Ltd - 541400 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended 30Th September, 2026.
Zim Laboratories will hold a board meeting on 04 Nov 2026. The board will consider and approve the financial results.
Oct 28 2026 16:12:48
Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zim Laboratories received a Certificate of GMP Compliance from Australia's TGA for its Kalmeshwar, Nagpur facility. The certification is valid until 21 June 2028 and covers non-sterile finished products, supporting expansion into Australian and RoW markets.
Oct 16 2026 12:54:22
Zim Laboratories Management
| Name | Position |
|---|---|
| Piyush Siddeshwar Nikhade | Company Secretary & Compliance Officer |
| Anwar Siraj Daud | Chairman & Managing Director |
Zim Laboratories Similar Stocks
Albert David Ltd.
785.00
-4.00 (0.51%)
Shree Ganesh Remedies Ltd.
657.95
14.65 (2.28%)
Gaudium IVF and Women Health Ltd.
106.14
-1.46 (1.36%)
Amanta Healthcare Ltd.
234.47
6.10 (2.67%)
Hexagon Nutrition Ltd.
58.70
-1.21 (2.02%)
Wanbury Ltd.
193.46
-6.48 (3.24%)
Kilitch Drugs (India) Ltd.
215.11
14.50 (7.23%)
Osel Devices Ltd.
384.35
-3.40 (0.88%)
Kaya Ltd.
342.20
-6.95 (1.99%)
Valiant Laboratories Ltd.
104.96
-2.14 (2.00%)
Zim Laboratories FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in ZIMLAB
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC